Overview

Amisulpride in Schizophrenic Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Primary purpose: - To find out how effective is long term treatment with amisulpride on the positive and negative symptoms in schizophrenic patients - To find out how safe is long term treatment with amisulpride in schizophrenic patients Secondary purpose: - To find out how effective is long term treatment with amisulpride on the quality of life in schizophrenic patients - To find out how effective is long term treatment with amisulpride on the cognitive function in schizophrenic patients
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Amisulpride
Sulpiride
Sultopride